These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10605476)

  • 21. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current management of acne.
    O'Loughlin S
    Ir Med J; 1997; 90(3):92-3. PubMed ID: 9183086
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
    Coates P; Vyakrnam S; Ravenscroft JC; Stables GI; Cunliffe WJ; Leyden JJ; Johnson J; Eady EA; Cove JH
    Br J Dermatol; 2005 Dec; 153(6):1126-36. PubMed ID: 16307647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
    Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does oral isotretinoin prevent Propionibacterium acnes resistance?
    Coates P; Adams CA; Cunliffe WJ; McGinley KT; Eady EA; Leyden JJ; Ravenscroft J; Vyakrnam S; Vowels B
    Dermatology; 1997; 195 Suppl 1():4-9; discussion 38-40. PubMed ID: 9310739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic possibilities for acne vulgaris].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1998 May; 21(5):154-6. PubMed ID: 9617104
    [No Abstract]   [Full Text] [Related]  

  • 31. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.
    Eady AE; Cove JH; Layton AM
    Am J Clin Dermatol; 2003; 4(12):813-31. PubMed ID: 14640775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
    Leyden JJ; Del Rosso JQ; Webster GF
    Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General antibiotic therapy in acne].
    Dréno B
    Rev Prat; 2002 Apr; 52(8):841-3. PubMed ID: 12053791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and bacteriologic evaluation of OPC-7251 in patients with acne: a double-blind group comparison study versus cream base.
    Kurokawa I; Akamatsu H; Nishijima S; Asada Y; Kawabata S
    J Am Acad Dermatol; 1991 Oct; 25(4):674-81. PubMed ID: 1838749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes.
    Yoon JY; Kwon HH; Min SU; Thiboutot DM; Suh DH
    J Invest Dermatol; 2013 Feb; 133(2):429-40. PubMed ID: 23096708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antimicrobial activities of Psidium guajava and Juglans regia leaf extracts to acne-developing organisms.
    Qadan F; Thewaini AJ; Ali DA; Afifi R; Elkhawad A; Matalka KZ
    Am J Chin Med; 2005; 33(2):197-204. PubMed ID: 15974479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Human beta defensins: a new perspective in acne treatment?].
    Körber A; Lehnen M; Grabbe S; Dissemond J
    Dtsch Med Wochenschr; 2005 Feb; 130(5):210-2. PubMed ID: 15678389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.